ElizabethARaetzMD

Pediatric Hematology & Oncology • New York, NY

Physician

Join to view full profile

Dr. Raetz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Raetz's full profile

Already have an account?

Office
160 E 32nd St
2nd Floor
New York, NY 10016
Phone+1 212-263-9918
Is this information wrong?

Education & Training

University of Utah HealthFellowship, Pediatric Hematology/Oncology, 1995 - 1998
University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 1992 - 1995
University of Wisconsin School of Medicine & Public HealthClass of 1992

Certifications & Licensure

NY State Medical License 2002 - 2025
UT State Medical License 1995 - 2020
MT State Medical License 2017 - 2019
WI State Medical License 1994 - 1995
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com

Clinical Trials

Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia Start of enrollment: 2003 Jan 01
Completed
Not Applicable
Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2005 Feb 01
Completed
Phase 1, Phase 2
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Start of enrollment: 2010 Jun 01
Terminated
Phase 1, Phase 2
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2010 Aug 24
Terminated
Phase 1
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies Start of enrollment: 2011 Mar 01
Completed
Phase 1
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL Start of enrollment: 2011 Dec 01
Terminated
Phase 1, Phase 2
Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) Start of enrollment: 2019 Apr 11
Active, not recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

3 citations
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
Meenakshi Devidas, Ryan J Summers, Zhiguo Chen, Patrick A Zweidler-McKay, Naomi J Winick, William L Carroll, Mignon L Loh, Stephen P Hunger, Kimberly P Dunsmore, Stuar...> ;Blood. 2023 Dec 14
mutations do not contribute to clonal fitness in response to chemotherapy in childhood B cell acute lymphoblastic leukemia.
Gloria P Contreras Yametti, Gabriel Robbins, Ashfiyah Chowdhury, Sonali Narang, Talia H Ostrow, Harrison Kilberg, Joshua Greenberg, Lindsay Kramer, Elizabeth Raetz, Ar...> ;Leukemia & Lymphoma. 2024 Jan 1
Flow cytometric assessment of leukemia-associated monocytes in childhood B-cell acute lymphoblastic leukemia outcome.
Gloria P Contreras Yametti, Nikki A Evensen, Jennifer M Schloss, Clemence Aldebert, Emily Duan, Yan Zhang, Jiyuan Hu, Tiffany M Chambers, Michael E Scheurer, David T T...> ;Blood Advances. 2023 Aug 8
2 citations
Impact of vincristine-steroid pulses during maintenance for B-cell pediatric ALL: a systematic review and meta-analysis.
Louise Guolla, Sara Breitbart, Farid Foroutan, Lehana Thabane, Mignon L Loh, David T Teachey, Elizabeth A Raetz, Sumit Gupta> ;Blood. 2023 Jun 15
1 citations
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia.
Elgarten, C., Otto, W., Shenton, L., Stein, M., Horowitz, J., Aftandilian, C., Arnold, S., Bona, K., Caywood, E., Collier, A., Gramatges, M., Henry, M., Lotterman, C.,...> ;Infection Control and Hospital Epidemiology. 2023 Feb 1
18 citations
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.
Sumit Gupta, Yunfeng Dai, Zhiguo Chen, Lena E Winestone, David T Teachey, Kira Bona, Richard Aplenc, Karen R Rabin, Patrick Zweidler-McKay, Andrew J Carroll, Nyla A He...> ;The Lancet. Haematology. 2023 Feb 1
8 citations
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.
Nathan P Gossai, Meenakshi Devidas, Zhiguo Chen, Brent L Wood, Patrick A Zweidler-McKay, Karen R Rabin, Mignon L Loh, Elizabeth A Raetz, Naomi J Winick, Michael J Burk...> ;Blood. 2023 Apr 13
1 citations
Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia.
Carolin Escherich, Wenan Chen, Satoshi Miyamoto, Yui Namikawa, Wenjian Yang, David T Teachey, Zhenhua Li, Elizabeth A Raetz, Eric Larsen, Meenakshi Devidas, Paul L Mar...> ;Blood Advances. 2023 May 23
6 citations
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia.
Wenjian Yang, Seth E Karol, Keito Hoshitsuki, Shawn Lee, Eric C Larsen, Naomi Winick, William L Carroll, Mignon L Loh, Elizabeth A Raetz, Stephen P Hunger, Stuart S Wi...> ;JAMA Network Open. 2022 Dec 1
1 citations
How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia?
Ashley Pinchinat, Elizabeth Raetz> ;Haematologica. 2022 Oct 1
Activation of the mitogen-activated protein kinase-extracellular signal-regulated kinase pathway in childhood B-cell acute lymphoblastic leukemia.
Pallavi M Pillai, Nicole Mallory, Joanna Pierro, Jason Saliba, Daniel Newman, Jiyuan Hu, Teena Bhatla, Elizabeth Raetz, William L Carroll, Nikki A Evensen> ;Pediatric Blood & Cancer. 2022 Oct 1
9 citations
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study.
Luke Maese, Mignon L Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Robert Iannone, Jeffrey A Silverman, Lewis B Silverman, Elizabeth A Ra...> ;Blood. 2023 Feb 16
2 citations
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's On...
Caitlin W Elgarten, Joel C Thompson, Anne Angiolillo, Zhiguo Chen, Susan Conway, Meenakshi Devidas, Sumit Gupta, John A Kairalla, Jennifer L McNeer, Maureen M O'Brien,...> ;Pediatric Blood & Cancer. 2022 Nov 1
82 citations
The genomic landscape of pediatric acute lymphoblastic leukemia.
Samuel W Brady, Kathryn G Roberts, Zhaohui Gu, Lei Shi, Stanley Pounds, Deqing Pei, Cheng Cheng, Yunfeng Dai, Meenakshi Devidas, Chunxu Qu, Ashley N Hill, Debbie Payne...> ;Nature Genetics. 2022 Sep 1
Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia.
Rozalyn L Rodwin, John A Kairalla, Emily Hibbitts, Meenakshi Devidas, Moira K Whitley, Caroline E Mohrmann, Reuven J Schore, Elizabeth Raetz, Naomi J Winick, Stephen P...> ;Journal of the National Cancer Institute. 2022 Aug 8
40 citations
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
David T Teachey, Meenakshi Devidas, Brent L Wood, Zhiguo Chen, Robert J Hayashi, Michelle L Hermiston, Robert D Annett, J Hunter Archer, Barbara L Asselin, Keith J Aug...> ;Journal of Clinical Oncology. 2022 Jul 1
4 citations
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia.
Xujie Zhao, Maoxiang Qian, Charnise Goodings, Yang Zhang, Wenjian Yang, Ping Wang, Beisi Xu, Cheng Tian, Ching-Hon Pui, Stephen P Hunger, Elizabeth A Raetz, Meenakshi ...> ;Journal of the National Cancer Institute. 2022 Sep 9
9 citations
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
Sumit Gupta, David T Teachey, Zhiguo Chen, Karen R Rabin, Kimberly P Dunsmore, Eric C Larsen, Kelly W Maloney, Leonard A Mattano Jr, Stuart S Winter, Andrew J Carroll,...> ;Cancer. 2022 May 1
10 citations
Outstanding outcomes in infants with-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial.
Erin M Guest, John A Kairalla, Joanne M Hilden, ZoAnn E Dreyer, Andrew J Carroll, Nyla A Heerema, Cindy Y Wang, Meenakshi Devidas, Lia Gore, Wanda L Salzer, Naomi J Wi...> ;Haematologica. 2022 May 1
33 citations
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol...
Maureen M O'Brien, Lingyun Ji, Nirali N Shah, Susan R Rheingold, Deepa Bhojwani, Constance M Yuan, Xinxin Xu, Joanna S Yi, Andrew C Harris, Patrick A Brown, Michael J ...> ;Journal of Clinical Oncology. 2022 Mar 20
19 citations
Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's On...
Michael J. Burke, Meenakshi Devidas, Zhiguo Chen, Wanda L. Salzer, Elizabeth A. Raetz, Karen R. Rabin, Nyla A. Heerema, Andrew J. Carroll, Julie M. Gastier-Foster, Mic...> ;Leukemia. 2021 Nov 1
6 citations
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.
Kelly D. Getz, Julia E. Szymczak, Yimei Li, Rachel Madding, Yuan-Shung Huang, Catherine Aftandilian, Staci D. Arnold, Kira Bona, Emi Caywood, Anderson B. Collier, M. M...> ;JAMA Network Open. 2021 Oct 1
4 citations
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia.
David Spencer Mangum, Julia Meyer, Clinton C. Mason, Soheil Shams, Luke Maese, Jamie D. Gardiner, Jonathan M. Downie, Deqing Pei, Cheng Cheng, Adam Gleason, Minjie Luo...> ;JAMA Oncology. 2021 Oct 1
10 citations
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia
Liv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, Shlomit Barzilai-Birenboim, Deepa Bhojwani, Melanie M Hagleitner, Christina Halsey, Arja Harila-Saari, Raphaele R L...> ;The Lancet. Haematology. 2021 Jul 1
17 citations
Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia.
Yizhen Li, Wentao Yang, Meenakshi Devidas, Stuart S. Winter, Chimene Kesserwan, Wenjian Yang, Kimberly P. Dunsmore, Colton Smith, Maoxiang Qian, Xujie Zhao, Ranran Zha...> ;The Journal of Clinical Investigation. 2021 Jun 24
Join now to see all

Journal Articles

Inotuzumab Ozogamicin in Pediatric Patients with relapsed/refractory Acute Lymphoblastic Leukemia
Deepa Bhojwani, Constance Yuan, Jennifer L McNeer, Mignon L Loh, Vilmarie Rodriguez, Susan R Rheingold, Elizabeth A Raetz, Nature
Genomic and Outcome Analyses of Ph-like ALL in NCI Standard-Risk Patients: A Report from the Children's Oncology Group
Michael J Borowitz, Nyla A Heerema, Brent L Wood, Elizabeth A Raetz, Stephen P Hunger, Andrew J Carroll, Mignon L Loh, Cheryl L Willman, Kelly W Maloney, Blood

Abstracts/Posters

The Genomic Landscape of Childhood Acute Lymphoblastic Leukemia
Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Identification of New Risk Loci and Regulatory Mechanisms Influencing Genetic Susceptibility to Acute Lymphoblastic Leukaemia
Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results fro...
Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Outcome in Adolescent and Young Adult (AYA) Patients Compared to Younger Patients Treated for High-Risk B-Lymphoblastic Leukemia (HR B-ALL): Report from the ChildrenÍs...
Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Open-Label, Multicenter, Phase 2/3 Study of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens (RC-P) in Patients with Acute Lymphoblastic Leukemia (ALL) or...
Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Germline RUNX1 Variation and Predisposition to T-Cell Acute Lymphoblastic Leukemia in Children
Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
FLT3 Inhibitor Correlative Laboratory Assays Impact Outcomes in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia (ALL) Patients Treated with Lestaurtinib: AALL0631...
Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic ...
Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Home or Away from Home: A Multi-Institution Study Comparing Medical Outcomes, Patient Perspectives, and Health-Related Quality of Life for Outpatient Versus Inpatient ...
Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all

Lectures

Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High ...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Induction Toxicities Are More Frequent in Young Adults Compared to Children Treated on the Children's Oncology Group (COG) First Relapse B-Lymphoblastic Leukemia Clini...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Pregnant ‘90 Day Fiance’ Star Deavan Clegg, 25, Says Her Son, 3, Has Cancer and Asks for Donations: ‘It’s the Most Vulnerable and Saddest Point of My Life’June 1st, 2022
Incorporating Immunotherapy for Relapsed Pediatric Acute Lymphoblastic LeukemiaAugust 13th, 2020
Why the Increase in Childhood Cancers? Groundbreaking New Study Invites Families to ‘Stand up and Be Counted’June 16th, 2020
Join now to see all